|
|
post embryonic development
|
GO:0009791 |
2 |
0.958
|
Worm |
|
|
ncrna metabolic process
|
GO:0034660 |
108 |
0.383
|
|
|
|
ribosome biogenesis
|
GO:0042254 |
48 |
0.262
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.200
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.183
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.175
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.133
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.130
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.115
|
|
|
|
rrna metabolic process
|
GO:0016072 |
40 |
0.094
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.094
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.094
|
Fly |
|
|
neuron development
|
GO:0048666 |
113 |
0.093
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.085
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.076
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.074
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.073
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.072
|
|
|
|
ncrna processing
|
GO:0034470 |
83 |
0.071
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.067
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.062
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.062
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.062
|
Fly |
|
|
embryo development
|
GO:0009790 |
123 |
0.061
|
Worm |
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.060
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.059
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.059
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.057
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.057
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.057
|
Worm |
|
|
molting cycle
|
GO:0042303 |
28 |
0.056
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.054
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.053
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.051
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.049
|
|
|
|
mitotic spindle elongation
|
GO:0000022 |
4 |
0.048
|
Fly |
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.048
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.044
|
|
|
|
regulation of oocyte development
|
GO:0060281 |
1 |
0.041
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.040
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.040
|
Fly |
|
|
actin filament based process
|
GO:0030029 |
224 |
0.040
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.036
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.036
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.036
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.035
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.034
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.033
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.033
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.033
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.032
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.032
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.032
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.032
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.029
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.028
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.028
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.027
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.027
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.027
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.026
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.026
|
Worm |
|
|
endocytosis
|
GO:0006897 |
159 |
0.026
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.026
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.026
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.026
|
|
|
|
mitochondrial transport
|
GO:0006839 |
60 |
0.026
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.025
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
50 |
0.025
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.025
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.024
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.023
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.023
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.023
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.023
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.023
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
3 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.023
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.023
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.021
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.021
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.021
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.021
|
|
|
|
myoblast migration
|
GO:0051451 |
1 |
0.021
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.020
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.019
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.019
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.019
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.019
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.018
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.018
|
|
|
|
growth
|
GO:0040007 |
202 |
0.018
|
|
|
|
nuclear migration
|
GO:0007097 |
1 |
0.018
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.018
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.018
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.018
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.017
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.017
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.017
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.017
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.017
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.017
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.016
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.016
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.016
|
|
|
|
nuclear division
|
GO:0000280 |
128 |
0.016
|
|
|
|
nucleus localization
|
GO:0051647 |
1 |
0.016
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.016
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.015
|
|
|
|
axon development
|
GO:0061564 |
34 |
0.015
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.015
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.015
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.015
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.015
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.015
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.015
|
|
|
|
gonad development
|
GO:0008406 |
34 |
0.015
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.014
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.014
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.014
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.014
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.014
|
|
|
|
skeletal muscle tissue growth
|
GO:0048630 |
2 |
0.014
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.013
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.013
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.013
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.013
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.013
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.013
|
|
|
|
glial cell migration
|
GO:0008347 |
4 |
0.013
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.013
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.013
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.013
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.013
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.013
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.013
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.013
|
|
|
|
axonogenesis
|
GO:0007409 |
31 |
0.012
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.012
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.012
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.012
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.012
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
72 |
0.012
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.012
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.012
|
|
|
|
maturation of lsu rrna
|
GO:0000470 |
3 |
0.012
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.012
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.012
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.012
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.011
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.011
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.011
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
44 |
0.011
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.011
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.011
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.011
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.011
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.011
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.011
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.011
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.011
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.010
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.010
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.010
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.010
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.010
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.010
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.010
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.010
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.010
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.010
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.010
|
|